AGA CLINICAL PRACTICE UPDATE: EXPERT REVIEW - Treatment of Dyslipidemia in Common Liver Diseases

Statins often (3%) cause benign elevations in serum ALT or AST levels and should not be considered contraindicated in patients with liver disease.